DEA role must be clearly defined in controlled substance Rx via telemedicine, expert cautions
If the DEA’s role is not properly limited, there could be an overreach where the agency influences or even dictates how healthcare practitioners make decisions, which could impact patient care, says Dan Cohen, president of RTM company Adhere+.
If the DEA’s role is not properly limited, there could be an overreach where the agency influences or even dictates how healthcare practitioners make decisions, which could impact patient care, says Dan Cohen, president of RTM company Adhere+.
Go to Source
2025-03-10 23:40
Except for the headline, this story has not been edited by Healthcare Central is published from a syndicated feed.
